Showing results (261-270 of 341) with videos related to
Sort By:
Pageof 35
Menopause (New York, N.Y.)|February 7, 2013
Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone lossRussell T Turner, Urszula T Iwaniec, Juan E Andrade, et al.Drug Safety|June 28, 2024
Use of the Sentinel System to Examine Medical Product Use and Outcomes During PregnancyJennifer G Lyons, Mayura U Shinde, Judith C Maro, et al.Pharmacoepidemiology and Drug Safety|February 14, 2006
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockersMarsha A Raebel, David L McClure, Steven R Simon, et al.International Journal for Parasitology. Parasites and Wildlife|April 11, 2020
Helminth communities of sigmonontine rodents in cocoa agroforestry systems in BrazilMaíra G Kersul, Natália A Costa, Raquel G Boullosa, et al.Arthritis and Rheumatism|February 3, 2007
Validity of gout diagnoses in administrative dataLeslie R Harrold, Kenneth G Saag, Robert A Yood, et al.Journal of Clinical Epidemiology|February 28, 2002
Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization studySusan E Andrade, Jerry H Gurwitz, K Arnold Chan, et al.American Journal of Obstetrics and Gynecology|October 2, 2007
Use of antidepressant medications during pregnancy: a multisite studySusan E Andrade, Marsha A Raebel, Jeffrey Brown, et al.Journal of Managed Care Pharmacy : JMCP|February 3, 2007
Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOsMarsha A Raebel, Nikki M Carroll, Steven R Simon, et al.Medicina Oral, Patologia Oral Y Cirugia Bucal|May 11, 2020
Epidemiologic analysis of salivary gland tumors over a 10-years period diagnosed in a northeast Brazilian populationJ-L Cunha, A-C Coimbra, J-V Silva, et al.American Journal of Preventive Cardiology|May 16, 2022
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent EthylCatherine G Derington, Adam P Bress, Jennifer S Herrick, et al.Pageof 35